Clinical trial
Efficacy and Safety of a Multistrain Probiotic Formula to Boost the Immune Response to Influenza Virus Vaccination
NCT05157425 is registered in ClinicalTrials.gov with AB Biotics, SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of a Multistrain Probiotic Formula to Boost the Immune Response to Influenza Virus Vaccination
- Lead sponsor
- AB Biotics, SA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 26, 2021
- Completion date
- May 31, 2022
- Enrollment
- 140 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
influenza vaccine